Dalbavancin 71839-0144-01

Package NDC

71839-0144-01

Manufacturer: Be Pharmaceuticals Inc.
Dosage Form: Injection, Powder, Lyophilized, For Solution
Route: Intravenous
Product Type: Human Prescription Drug
Marketing Start: June 12, 2026
Listing Expires: December 31, 2027
Application: ANDA219604

Need to source Dalbavancin? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Dalbavancin Hydrochloride	500 mg/25mL

Drug Class

Lipoglycopeptide Antibacterial [EPC]Lipoglycopeptides [CS]

Selected Package

71839-0144-01Selected

1 VIAL in 1 CARTON (71839-144-01) / 25 mL in 1 VIAL